申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US06355663B1
公开(公告)日:2002-03-12
This invention provides a substituted isoxazolylthiophene compound represented by the formula
wherein R1 and R2 individually represent an alkyl group of 1-5 carbon atoms, R3 represents a cyano group or a group CONR5R6 (in which R5 and R6 individually represent a hydrogen atom or an alkyl group of 1-10 carbon atoms), R4 represents an alkyl group of 1-5 carbon atoms or a phenyl group, and n is an integer of 0-2, or a salt thereof.
The compounds of the invention are useful for the treatment or prevention of various bone diseases or nerve diseases, because they specifically enhance the action of the cell differentiation induction factors found in a living body.
这项发明提供了一种被代表为式的取代异噁唑基硫代苯并化合物,其中R1和R2分别表示1-5个碳原子的烷基基团,R3表示氰基或CONR5R6基团(其中R5和R6分别表示氢原子或1-10个碳原子的烷基基团),R4表示1-5个碳原子的烷基基团或苯基,n是0-2的整数,或其盐。该发明的化合物可用于治疗或预防各种骨疾病或神经疾病,因为它们特异性地增强了存在于生物体中的细胞分化诱导因子的作用。